ArticleJournal of personalized medicine2021

Stimulated Expression of CXCL12 in Adrenocortical Carcinoma by the PPARgamma Ligand Rosiglitazone Impairs Cancer Progression.

Giulia Cantini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.